NASDAQ:PACB

Pacific Biosciences Of California Stock News

etoro logo Buy PACB
*Your capital is at risk
$1.45
-0.180 (-11.04%)
At Close: Jun 05, 2026
Pacific Biosciences (PACB) delivered earnings and revenue surprises of 21.05% and 23.36%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
MENLO PARK, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its second quarter ended June 30, 2020. Total revenu
Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, and Asuragen, a molecular diagnostics company delivering
Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, and As
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.COVID-19 news flow continued to pour in, with big pharma tie-ups f
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts. COVID-19 news flow continued to pour in,...
Pacific Biosciences (PACB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Pacific Biosciences of California (NASDAQ:PACB) is scheduled to be posting its quarterly earnings results after the market closes on Monday, August 3rd. Analysts expect Pacific Biosciences of Californ
Four coronavirus patients linked to a cluster at Bukit Panjang Integrated Transport Hub are all bus drivers, said transport operator SMRT yesterday.. Read more at straitstimes.com.
SINGAPORE - Four coronavirus patients linked to a cluster at Bukit Panjang Integrated Transport Hub are all bus drivers, said transport operator SMRT on Sunday (July 26).. Read more at straitstimes.co
MENLO PARK, Calif., July 24, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Second Quarter 2020 Financial Result
KUALA LUMPUR (July 14) : SMRT Holdings Bhd, whose net loss widened in the first quarter ended March 31, 2020 (1QFY20), is selling off two subsidiaries— Talentoz Sdn Bhd and Forzia Tech Pte Ltd— fo
Geode Capital Management LLC grew its position in shares of Pacific Biosciences of California (NASDAQ:PACB) by 6.2% during the first quarter, according to its most recent filing with the SEC. The firm
Victory Capital Management Inc. trimmed its holdings in Pacific Biosciences of California (NASDAQ:PACB) by 22.4% in the first quarter, according to its most recent disclosure with the SEC. The fund ow
Brokerages forecast that Pacific Biosciences of California (NASDAQ:PACB) will post earnings per share of ($0.19) for the current quarter, according to Zacks. Three analysts have issued estimates for P
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE